Neuroglial Senescence, α-Synucleinopathy, and the Therapeutic Potential of Senolytics in Parkinson’s Disease

Parkinson’s disease (PD) is the most common movement disorder and the second most prevalent neurodegenerative disease after Alzheimer’s disease. Despite decades of research, there is still no cure for PD and the complicated intricacies of the pathology are still being worked out. Much of the researc...

Descripción completa

Detalles Bibliográficos
Autores principales: Miller, Sean J., Campbell, Cameron E., Jimenez-Corea, Helen A., Wu, Guan-Hui, Logan, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9063319/
https://www.ncbi.nlm.nih.gov/pubmed/35516803
http://dx.doi.org/10.3389/fnins.2022.824191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9063319/
https://www.ncbi.nlm.nih.gov/pubmed/35516803
http://dx.doi.org/10.3389/fnins.2022.824191

Ejemplares similares